Doctor of Podiatric Medicine Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Nicholas Hugentobler

Podiatrist, Foot & Ankle Surgery Durango, CO Doctor of Podiatric Medicine

NPI 1508096116 CMS profile 68284

270 E 8Th Ave, Suite N102, Durango, CO 81301

Open in the dashboard

General payments

$26,095

65 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$14,103 paid to institutions, not to them · program year 2019

Through program year 2025, Nicholas Hugentobler of Durango, CO is reported in the CMS Open Payments database as having received $26,095 across 65 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $14,103 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 93rd percentile of Podiatrist, Foot & Ankle Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $131 3
2024 General $20 1
2023 General $122 4
2022 General $80 4
2021 General $12,436 31
2020 General $9,321 15
2019 General $3,986 7

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Nicholas Hugentobler
  • Podiatrist, Foot & Ankle Surgery median
  • Middle half of Podiatrist, Foot & Ankle Surgery
  • National median

In program year 2025, general payments to Nicholas Hugentobler were reported at $131. Among 6,994 Podiatrist, Foot & Ankle Surgery profiles paid that year, the median was $424 and the middle half received between $139 and $1,306.

Show as a table
Year Nicholas Hugentobler Podiatrist, Foot & Ankle Surgery median Middle half National median
2019 $3,986 $389 $118–$1,406 $163
2020 $9,321 $191 $62–$691 $114
2021 $12,436 $329 $104–$1,341 $132
2022 $80 $419 $125–$1,611 $149
2023 $122 $377 $128–$1,164 $160
2024 $20 $394 $134–$1,168 $164
2025 $131 $424 $139–$1,306 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Vilex in Tennessee, Inc. $8,906 15 payments
  2. Novastep Inc. $7,334 1 payment
  3. In2Bones USA, LLC $5,251 17 payments
  4. CurveBeam LLC $2,200 1 payment
  5. Flower Orthopedics Coporation $1,527 2 payments
  6. Organogenesis Inc. $160 9 payments
  7. Gemini Mountain Medical, LLC $120 2 payments
  8. Linvatec Corporation $103 3 payments
  9. Smith+Nephew, Inc. $85 4 payments
  10. Trilliant Surgical LLC. $82 1 payment
  11. Other $326 10 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $9,534 2 payments
  2. Education $6,064 1 payment
  3. Consulting Fee $4,800 5 payments
  4. Travel and Lodging $4,111 11 payments
  5. Food and Beverage $1,337 35 payments
  6. Royalty or License $249 11 payments
Products named General payments · program years 2019–2025
  1. HINTERMANN $6,064 1 payment
  2. TAR $2,842 14 payments
  3. CoLink $2,548 5 payments
  4. NeoSpan $2,102 2 payments
  5. IBS $592 10 payments
  6. Quantum Total Ankle $259 3 payments
  7. 5MS $213 2 payments
  8. Puraply $145 8 payments
  9. NEOSPAN SUPERELASTIC COMPRESSION STAPLE W/INSTRUMENTS, SIZE 10X10X10 $103 3 payments
  10. Vitrium $102 1 payment
  11. Other $502 18 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 16 drugs

Part D claims

731

Median for Podiatry: 160

Drug cost

$11,157

Median for Podiatry: $2,368

Branded share of claims

21.1%

Median for Podiatry: 12.7%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Xarelto Rivaroxaban Brand 12 $4,271
Pregabalin Generic 58 $1,241
Terbinafine Hcl Generic 87 $1,138
Gabapentin Generic 85 $752
Cephalexin Generic 125 $685
Nitro-Bid Nitroglycerin Brand 13 $677
Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav Brand 60 $587
Doxycycline Hyclate Generic 41 $354
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 35 $291
Methylprednisolone Generic 48 $255

The 10 drugs with the highest cost, of 16 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 14,093 Part D prescribers listed as Podiatry; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 130 billing codes

Paid by Medicare

$5,845,989

Of which drugs: $5,443,189

Medicare patients

669

Average age 76

Services billed

12,143

388 women, 281 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 71%
Arthritis 56%
Diabetes 34%
Depression 28%
Chronic kidney disease 25%
Ischemic heart disease 24%
Atrial fibrillation 22%
Alzheimer's or dementia 20%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Xwrap, per square centimeter Q4204 Office 15 1,112 $2,742,266
Membrane graft or membrane wrap, per square centimeter Q4205 Office 11 836 $859,761
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 45 174 $131
Injection, dexamethasone sodium phosphate, 1 mg J1100 Office 46 386 $34

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

65 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Podiatrist, Foot & Ankle Surgery in Colorado

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record